C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2011
11/03/2011	WO2011136307A1 Prophylactic or therapeutic agent for night urination
11/03/2011	WO2011136292A1 Novel amide derivative and use thereof as medicine
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011	WO2011134912A1 Fungicide hydroximoyl-heterocycles derivatives
11/03/2011	WO2011134911A2 Fungicide hydroximoyl-tetrazole derivatives
11/03/2011	WO2011098408A3 Hydrazine-substituted anthranilic acid derivatives
11/03/2011	WO2011089576A3 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad)
11/03/2011	WO2011062437A3 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/03/2011	WO2011053090A3 Novel 2, 4-pyrimidine derivatives and use thereof
11/03/2011	WO2010116282A8 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
11/03/2011	WO2010052569A8 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/03/2011	US20110271406 Condensed anthran i lami de derivatives as insecticides
11/03/2011	US20110269967 Aromatic amic acids or amic esters and compositions
11/03/2011	US20110269966 Semiconducting articles
11/03/2011	US20110269960 Triazole derivative
11/03/2011	US20110269958 Pyridons as pdk1 inhibitors
11/03/2011	US20110269806 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
11/03/2011	US20110269800 P38 map kinase inhibitors
11/03/2011	US20110269798 Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
11/03/2011	US20110269774 Pyrazolylaminopyridines as inhibitors of fak
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269767 Novel Polymorphic Forms of 3-(1--6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile Hydrochloride Salt and Processes of Manufacturing Thereof
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269746 Cyclic compound having hetero atom
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269742 Serotonin 5-HT2B Receptor Inhibitors
11/03/2011	US20110269741 Novel compositions and methods of use
11/03/2011	US20110269737 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases
11/03/2011	US20110269734 Piperidinyl gpcr agonists
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269732 Drug discovery methods
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269677 Oligomer-Protease Inhibitor Conjugates
11/03/2011	US20110266527 Pyrrole compound and organic photoelectric device including the same
11/03/2011	CA2793859A1 Therapeutic agent and preventative agent for alzheimer's disease
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/03/2011	CA2738543A1 Precursor phase and its use in preparing magnesium tetrahydrate salt of an enantiomer of omeprazole
11/02/2011	EP2383269A2 Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
11/02/2011	EP2383268A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
11/02/2011	EP2383267A1 Substituted sulfonamide derivatives
11/02/2011	EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2382205A2 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
11/02/2011	EP2382204A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
11/02/2011	EP2382203A1 Bicyclic heterocycle derivatives and methods of use thereof
11/02/2011	EP2382202A1 Dihydropyridone amides as p2x7 modulators
11/02/2011	EP2382196A2 Imine compounds for combating invertebrate pests
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2382190A1 Toluidine sulfonamides and their use as-inhibitors
11/02/2011	EP2381943A1 Substituted quinazoline compounds
11/02/2011	EP2381941A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
11/02/2011	EP2381783A1 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
11/02/2011	EP2381779A1 Selective inhibitors of akt and methods of using same
11/02/2011	EP2381778A1 C5ar antagonists
11/02/2011	EP2294063B1 Pyrrolidine ether derivatives as nk3 receptor antagonists
11/02/2011	EP2283008B1 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/02/2011	EP2278973B1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
11/02/2011	EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011	EP2013183B1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor
11/02/2011	EP1994019B1 Novel piperidin - substituted indoles and their use as ccr-3 modulators
11/02/2011	EP1960387B1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
11/02/2011	EP1838674B9 Heteroaryl sulfonamides and ccr2
11/02/2011	EP1758883B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
11/02/2011	EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011	EP1667682B1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/02/2011	CN202022871U Device for preparing pantoprazole sodium
11/02/2011	CN102232071A Fused multicyclic compounds as protein kinase inhibitors
11/02/2011	CN102232067A Nicotinamide derivatives
11/02/2011	CN102229800A Pyrazoline derivative Zn<2+> fluorescence probe and its application
11/02/2011	CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011	CN102229602A Tacrine heterocomplex, preparation method and use in medicines for curing neurodegenerative diseases thereof
11/02/2011	CN102229601A Hexahydro-1-(5-isoquinoline sulfonyl)-1 (H)-1, 4- diazepine hydrochloride amorphous compound
11/02/2011	CN102229600A Cis-neonicotinoid compound containing 1, 4-dihydropyridine ring and its preparation method and application
11/02/2011	CN102229599A 1,4- dihydropyridine ring-containing cis-nitenpyram compound, preparation method and application thereof
11/02/2011	CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors
11/02/2011	CN102229565A Spirofluorene bisbenzoacridine organic semiconductor material, preparation method and use method thereof
11/02/2011	CN102229563A 4-amino quinoline derivative, preparation method and application thereof
11/02/2011	CN101511798B [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
11/01/2011	US8049016 Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes
11/01/2011	US8049008 Reverse-turn mimetics and method relating thereto
11/01/2011	US8048898 Inhibitor of binding of S1P1
11/01/2011	US8048895 Kappa opioid receptor ligands
11/01/2011	US8048893 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
11/01/2011	US8048889 3,4-disubstituted coumarin and quinolone compounds
11/01/2011	US8048883 Chronic Myelogenous Leukemia; crystal form stable at room temperature or higher temperatures up to 120 degrees C. and accelerated stress conditions, freely soluble in water; suspending Imatinib base in isopropanol and adding methane sulfonic acid at room temperature then cooling after reactoion
11/01/2011	CA2671949C Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
11/01/2011	CA2663408C Substituted pyridylmethyl bicyclocarboxyamide compounds
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2645257C Sulfonyl benzimidazole derivatives
11/01/2011	CA2545644C Melanocortin receptor agonists
11/01/2011	CA2499825C Radiolabeled neurokinin-1 receptor antagonists
11/01/2011	CA2493208C Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011	CA2479012C Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase

1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 1080